Butyrate inhibits the mitochondrial complex Ι to mediate mitochondria-dependent apoptosis of cervical cancer cells

被引:8
作者
Zhang, Ke [1 ]
Ji, Xiawei [2 ]
Song, Zhengyang [1 ]
Song, Wenjing [1 ]
Huang, Qunjia [1 ]
Yu, Tiantian [1 ]
Shi, Dibang
Wang, Fangyan [1 ]
Xue, Xiangyang [3 ]
Guo, Junping [4 ]
机构
[1] Wenzhou Med Univ, Sch Basic Med Sci, Dept Pathophysiol, Wenzhou 325000, Peoples R China
[2] Wenzhou Med Univ, Yuying Childrens Hosp, Affiliated Hosp 2, Dept Gastroenterol, Wenzhou 325000, Peoples R China
[3] Wenzhou Med Univ, Inst Mol Virol & Immunol, Sch Basic Med Sci,Wenzhou Collaborat Innovat Ctr, Dept Microbiol & Immunol,Wenzhou Key Lab Cancer r, Wenzhou 325000, Peoples R China
[4] Wuyunshan Hosp Hangzhou, Hlth Promot & Res Inst Hangzhou, Hangzhou 310000, Peoples R China
关键词
Butyrate; Cervical cancer; Mitochondria; Apoptosis; Mitochondrial complex Iota; SODIUM-BUTYRATE; RISK; PAPILLOMAVIRUS; PROLIFERATION; SUPPRESSES; ROTENONE;
D O I
10.1186/s12906-023-04043-3
中图分类号
R [医药、卫生];
学科分类号
10 ;
摘要
Background Cervical cancer (CC) is a common gynecological malignancy with high morbidity worldwide. Butyrate, a short-chain fatty acid produced by intestinal flora, has been reported to inhibit cervical carcinogenesis. This study aimed to investigate the pro-apoptotic effects of butyrate on CC and the underlying mechanisms. Methods Human HeLa and Ca Ski cells were used in this study. Cell proliferation, cell migration and invasion were detected by CCK-8 and EdU staining, transwell and wound healing assay, respectively. Cell cycle, mitochondrial membrane potential and apoptosis were evaluated by flow cytometry. Western blot and RT-qPCR were carried out to examine the related genes and proteins to the mitochondrial complex Iota and apoptosis. Metabolite changes were analyzed by energy metabolomics and assay kits. The association between G protein-coupled receptor 41, 43, 109a and CC prognosis was analyzed using data from The Cancer Genome Atlas (TCGA). Results CCK-8 results showed significant inhibition of CC cell proliferation induced by butyrate treatment, which was confirmed by EdU staining and cell cycle detection. Data from the transwell and wound healing assay revealed that CC cell migration was dramatically reduced following butyrate treatment. Additionally, invasiveness was also decreased by butyrate. Western blot analysis showed that cleaved Caspase 3 and cleaved PARP, the enforcers of apoptosis, were increased by butyrate treatment. The results of Annexin V/PI staining and TUNEL also showed an increase in butyrate-induced apoptotic cells. Expression of Cytochrome C (Cytc), Caspase 9, Bax, but not Caspase 12 or 8, were up-regulated under butyrate exposure. Mechanistically, the decrease in mitochondrial NADH and NAD+levels after treatment with butyrate was observed by energy metabolomics and the NAD+/NADH Assay Kit, similar to the effects of the complex Iota inhibitor rotenone. Western blot results also demonstrated that the constituent proteins of mitochondrial complex Iota were reduced by butyrate. Furthermore, mitochondria-dependent apoptosis has been shown to be initiated by inhibition of the complex Iota. Conclusion Collectively, our results revealed that butyrate inhibited the proliferation, migration and invasion of CC cells, and induced mitochondrial-dependent apoptosis by inhibiting mitochondrial complex Iota.
引用
收藏
页数:14
相关论文
共 44 条
[1]   Integrative Transcriptomic Network Analysis of Butyrate Treated Colorectal Cancer Cells [J].
Ali, Saira R. ;
Orang, Ayla ;
Marri, Shashikanth ;
McKinnon, Ross A. ;
Meech, Robyn ;
Michael, Michael Z. .
CANCERS, 2021, 13 (04) :1-26
[2]   Estimates of incidence and mortality of cervical cancer in 2018: a worldwide analysis [J].
Arbyn, Marc ;
Weiderpass, Elisabete ;
Bruni, Laia ;
de Sanjose, Silvia ;
Saraiya, Mona ;
Ferlay, Jacques ;
Bray, Freddie .
LANCET GLOBAL HEALTH, 2020, 8 (02) :E191-E203
[3]   Cervical Microbiome and Cytokine Profile at Various Stages of Cervical Cancer: A Pilot Study [J].
Audirac-Chalifour, Astride ;
Torres-Poveda, Kirvis ;
Bahena-Roman, Margarita ;
Tellez-Sosa, Juan ;
Martinez-Barnetche, Jesus ;
Cortina-Ceballos, Bernardo ;
Lopez-Estrada, Guillermina ;
Delgado-Romero, Karina ;
Burguete-Garcia, Ana I. ;
Cantu, David ;
Garcia-Carranca, Alejandro ;
Madrid-Marina, Vicente .
PLOS ONE, 2016, 11 (04)
[4]  
Bjurberg M, 2015, Lakartidningen, P112
[5]   Vaginal dysbiosis and the risk of human papillomavirus and cervical cancer: systematic review and meta-analysis [J].
Brusselaers, Nele ;
Shrestha, Sadeep ;
van de Wijgert, Janneke ;
Verstraelen, Hans .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2019, 221 (01) :9-+
[6]   Glucose Modulates Respiratory Complex I Activity in Response to Acute Mitochondrial Dysfunction [J].
Cannino, Giuseppe ;
El-Khoury, Riyad ;
Pirinen, Marja ;
Hutz, Bettina ;
Rustin, Pierre ;
Jacobs, Howard T. ;
Dufour, Eric .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2012, 287 (46) :38729-38740
[7]   Variations in cervico-vaginal microbiota among HPV-positive and HPV-negative asymptomatic women in Peru [J].
Carrillo-Ng, Hugo ;
Becerra-Goicochea, Lorena ;
Tarazona-Castro, Yordi ;
Pinillos-Vilca, Luis ;
del Valle, Luis J. ;
Angel Aguilar-Luis, Miguel ;
Tinco-Valdez, Carmen ;
Silva-Caso, Wilmer ;
Martins-Luna, Johanna ;
Pena-Tuesta, Isaac ;
Aquino-Ortega, Ronald ;
del Valle-Mendoza, Juana .
BMC RESEARCH NOTES, 2021, 14 (01)
[8]   Synergistic Interactions between HDAC and Sirtuin Inhibitors in Human Leukemia Cells [J].
Cea, Michele ;
Soncini, Debora ;
Fruscione, Floriana ;
Raffaghello, Lizzia ;
Garuti, Anna ;
Emionite, Laura ;
Moran, Eva ;
Magnone, Mirko ;
Zoppoli, Gabriele ;
Reverberi, Daniele ;
Caffa, Irene ;
Salis, Annalisa ;
Cagnetta, Antonia ;
Bergamaschi, Micaela ;
Casciaro, Salvatore ;
Pierri, Ivana ;
Damonte, Gianluca ;
Ansaldi, Filippo ;
Gobbi, Marco ;
Pistoia, Vito ;
Ballestrero, Alberto ;
Patrone, Franco ;
Bruzzone, Santina ;
Nencioni, Alessio .
PLOS ONE, 2011, 6 (07)
[9]   A novel drug screening assay for papillomavirus specific antiviral activity [J].
Clark, PR ;
Roberts, ML ;
Cowsert, LM .
ANTIVIRAL RESEARCH, 1998, 37 (02) :97-106
[10]  
Decrion-Barthod AZ, 2010, ANTICANCER RES, V30, P4049